Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Tough

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Clinical Medicine (London, England)|December 5, 2015
Epigenetic mechanisms and drug discovery in rheumatologyDavid F Tough, Rab K Prinjha, Paul P Tak
European Journal of Immunology|March 3, 2007
A role for CD44 in T cell development and function during direct competition between CD44+ and CD44- cellsVictoria A Graham, Amanda L Marzo, David F Tough
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cellsJagadeesh Bayry, Frédéric Triebel, Srini V Kaveri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
IL-15 promotes the survival of naive and memory phenotype CD8+ T cellsMarion Berard, Katja Brandt, Silvia Bulfone-Paus, et al.
European Journal of Immunology|June 23, 2009
Type I IFN regulate DC turnover in vivoFabrizio Mattei, Laura Bracci, David F Tough, et al.
Trends in Immunology|December 10, 2019
Epigenetic Regulation of T Cell Memory: Recalling Therapeutic ImplicationsDavid F Tough, Inma Rioja, Louise K Modis, et al.
Nature Reviews. Microbiology|December 19, 2007
From 'perfect mix' to 'potion magique'-- regulatory T cells and anti-inflammatory cytokines as adjuvant targetsJagadeesh Bayry, Darren R Flower, David F Tough, et al.
Immunology and Cell Biology|November 20, 2004
Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-alpha/betaVanessa Durand, Simon Yc Wong, David F Tough, et al.
Nature Reviews. Drug Discovery|November 4, 2016
Epigenetic drug discovery: breaking through the immune barrierDavid F Tough, Paul P Tak, Alexander Tarakhovsky, et al.
Drug Discovery Today|July 17, 2007
Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapyJagadeesh Bayry, Sophie Sibéril, Frédéric Triebel, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Clinical Medicine (London, England)|December 5, 2015
Epigenetic mechanisms and drug discovery in rheumatologyDavid F Tough, Rab K Prinjha, Paul P Tak
European Journal of Immunology|March 3, 2007
A role for CD44 in T cell development and function during direct competition between CD44+ and CD44- cellsVictoria A Graham, Amanda L Marzo, David F Tough
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cellsJagadeesh Bayry, Frédéric Triebel, Srini V Kaveri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
IL-15 promotes the survival of naive and memory phenotype CD8+ T cellsMarion Berard, Katja Brandt, Silvia Bulfone-Paus, et al.
European Journal of Immunology|June 23, 2009
Type I IFN regulate DC turnover in vivoFabrizio Mattei, Laura Bracci, David F Tough, et al.
Trends in Immunology|December 10, 2019
Epigenetic Regulation of T Cell Memory: Recalling Therapeutic ImplicationsDavid F Tough, Inma Rioja, Louise K Modis, et al.
Nature Reviews. Microbiology|December 19, 2007
From 'perfect mix' to 'potion magique'-- regulatory T cells and anti-inflammatory cytokines as adjuvant targetsJagadeesh Bayry, Darren R Flower, David F Tough, et al.
Immunology and Cell Biology|November 20, 2004
Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-alpha/betaVanessa Durand, Simon Yc Wong, David F Tough, et al.
Nature Reviews. Drug Discovery|November 4, 2016
Epigenetic drug discovery: breaking through the immune barrierDavid F Tough, Paul P Tak, Alexander Tarakhovsky, et al.
Drug Discovery Today|July 17, 2007
Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapyJagadeesh Bayry, Sophie Sibéril, Frédéric Triebel, et al.
Pageof 9